Vivos to acquire sleep center
By HME News Staff
Updated 10:29 AM CDT, Thu April 17, 2025
LITTLETON, Colo. - Vivos Therapeutics has signed a definitive agreement to acquire The Sleep Center of Nevada for up to $9 million.
The deal includes $6 million in cash, $1.5 million in Vivos common stock at closing, and potential additional $1.5 million in stock tied to performance milestones.
SCN, founded in 2008, is the largest sleep center in Nevada, with approximately 3,000 new patients each month. It operates seven locations with nearly 50 beds for overnight sleep testing.
“We believe this transaction will be a game-changer for Vivos, with the prospect of meaningfully adding to our revenues in the coming months through SCN’s diagnostic and other services as well as adding thousands of patients as candidates for Vivos OSA treatment,” said Kirk Huntsman, chairman and CEO of Vivos. “SCN has a dominant market share for OSA detection and treatment in the fast-growing Las Vegas region. We anticipate SCN patients will prefer Vivos treatment options over a lifelong maintenance device such as CPAP.”
Significant Vivos investor New Seneca Partners, Inc., a leading North American private equity sponsor, assisted in sourcing, structuring and executing this transaction. The acquisition is expected to close later this quarter or in the third quarter, subject to financing, audit and other customary conditions.
Comments